What was Abeona Therapeutics’s price range in the past 12 months?
Abeona Therapeutics lowest share price was $2.90 and its highest was $8.80 in the past 12 months.
What is Abeona Therapeutics’s market cap?
Currently, no data Available
When is Abeona Therapeutics’s upcoming earnings report date?
Abeona Therapeutics’s upcoming earnings report date is May 10, 2024 which is in 20 days.
How were Abeona Therapeutics’s earnings last quarter?
Abeona Therapeutics released its earnings results on Mar 18, 2024. The company reported -$0.59 earnings per share for the quarter, missing the consensus estimate of -$0.47 by -$0.12.
Abeona Therapeutics does not currently pay dividends.
What is Abeona Therapeutics’s EPS estimate?
Abeona Therapeutics’s EPS estimate is -$0.57.
How many shares outstanding does Abeona Therapeutics have?
Abeona Therapeutics has 27,355,038 shares outstanding.
What happened to Abeona Therapeutics’s price movement after its last earnings report?
Abeona Therapeutics reported an EPS of -$0.59 in its last earnings report, missing expectations of -$0.47. Following the earnings report the stock price went down -18.992%.
Which hedge fund is a major shareholder of Abeona Therapeutics?
Among the largest hedge funds holding Abeona Therapeutics’s share is Western Standard Llc. It holds Abeona Therapeutics’s shares valued at 4M.
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.
Copying Kristen Kluska's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.08% per trade.